Thus as in patients15,16, single-agent anti-PD-1 produced a characteristic long-tail survival curve with significant benefit for the mice where tumor growth inhibition was observed (Fig. 1e; Supplementary Fig. 2a). Here, PDCD1 is linked to neoplasm.